Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Inhaled Budesonide in Very Preterm Infants at Risk for Bronchopulmonary Dysplasia

NCT01035190 is registered in ClinicalTrials.gov with University Children's Hospital Tuebingen as lead sponsor.

NCT NCT01035190
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01035190 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Inhaled Budesonide in Very Preterm Infants at Risk for Bronchopulmonary Dysplasia
Lead sponsor
University Children's Hospital Tuebingen
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2010
Completion date
July 31, 2016
Enrollment
863 (actual)
Sites
40

Conditions

As the registry lists them; a condition with its own page is linked.

bronchopulmonary dysplasia